Patients with Advanced Pancreatic Cancer and Hyperbilirubinaemia: Review and German Expert Opinion on Treatment with nab-Paclitaxel plus Gemcitabine (vol 38, pg 596, 2015)

被引：0
|
作者：
Vogel, Arndt [1 ]
Kullmann, Frank [2 ]
Kunzmann, Volker [3 ]
Al-Batrand, Salah-Eddin [4 ]
Oettle, Helmut [5 ]
Plentz, Ruben [6 ]
Siveke, Jens [7 ]
Springfeld, Christoph [8 ]
Riess, Hanno [9 ]
机构：
[1] Hannover Med Sch, Klin Gastroenterol Hepatol & Endokrinol, Hannover, Germany
[2] Klinikum Weiden, Med Klin 1, Weiden, Germany
[3] Univ Klinikum, Med Klin & Poliklin 2, Schwerpunkt Med Onkol, Wurzburg, Germany
[4] Univ Canc Ctr, Krankenhaus Nordwest, Frankfurt, Germany
[5] Onkol Schwerpunktpraxis, Friedrichshafen, Germany
[6] Univ Clin Tubingen, Tubingen, Germany
[7] Tech Univ Munich, Klinikum Rechts Isar, Med Klin 2, D-80290 Munich, Germany
[8] Univ Heidelberg Hosp, Natl Ctr Tumor Dis, Heidelberg, Germany
[9] Charite, Med Klin Schwerpunkt Hamatol Onkol & Tumorimmunol, Berlin, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2015年 / 38卷 / 12期
关键词：
D O I：
10.1159/000442191
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：691 / 691
页数：1
相关论文
共 50 条
  • [31] Association between the use of antibiotics and efficacy of gemcitabine plus nab-paclitaxel in advanced pancreatic cancer
    Nakano, Shintaro
    Komatsu, Yoshito
    Kawamoto, Yasuyuki
    Saito, Rika
    Ito, Ken
    Nakatsumi, Hiroshi
    Yuki, Satoshi
    Sakamoto, Naoya
    MEDICINE, 2020, 99 (39) : E22250
  • [32] Clinical Significance of Increased Skeletal Muscle Mass During Nab-Paclitaxel Plus Gemcitabine Treatment in Patients With Advanced Pancreatic Cancer
    Iede, Kiyotsugu
    Yamada, Terumasa
    Ishida, Tomo
    Tsuda, Yujiro
    Nakashima, Shinsuke
    Tanida, Tsukasa
    Matsuyama, Jin
    Nakata, Ken
    Tominaga, Shusei
    PANCREAS, 2024, 53 (01) : e22 - e26
  • [33] Gemcitabine Plus nab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial
    Von Hoff, Daniel D.
    Ramanathan, Ramesh K.
    Borad, Mitesh J.
    Laheru, Daniel A.
    Smith, Lon S.
    Wood, Tina E.
    Korn, Ronald L.
    Desai, Neil
    Trieu, Vuong
    Iglesias, Jose L.
    Zhang, Hui
    Soon-Shiong, Patrick
    Shi, Tao
    Rajeshkumar, N. V.
    Maitra, Anirban
    Hidalgo, Manuel
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (34) : 4548 - 4554
  • [34] Neo-adjuvant treatment in patients with pancreatic cancer with nab-paclitaxel and gemcitabine
    Pomillo, A.
    Santoro, M.
    Iuliano, E.
    Luci, M.
    Perricelli, A.
    Iuliano, F.
    Mazzulla, M. F.
    ANNALS OF ONCOLOGY, 2016, 27
  • [35] Biweekly Gemcitabine/Nab-Paclitaxel as First-line Treatment for Advanced Pancreatic Cancer
    Kokkali, Stefania
    Tripodaki, Elli-Sophia
    Drizou, Maria
    Stefanou, Dimitra
    Magou, Elpida
    Zylis, Dimosthenis
    Kapiris, Matthaios
    Nasi, Despoina
    Georganta, Chara
    Ardavanis, Alexandros
    IN VIVO, 2018, 32 (03): : 653 - 657
  • [36] Phase I study of nab-paclitaxel and gemcitabine combination in patients with advanced pancreatic cancer
    Drengler, R. L.
    Smith, L. S.
    Wood, T. E.
    Borad, M. J.
    Ramanathan, R. K.
    Laheru, D. A.
    Hidalgo, M.
    Von Hoff, D. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [37] Gemcitabine (Gem) and nab-paclitaxel (nab-P) in patients (pts) with refractory advanced pancreatic cancer
    Palacio, Sofia
    Akunyili, Ikechukwu Immanuel
    Ernani, Vinicius
    Macintyre, Jessica
    Merchan, Jaime R.
    Pollack, Terri
    Reis, Isildinha
    Restrepo, Maria H.
    Lima, Caio Max S. Rocha
    Hosein, Peter Joel
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [38] Gemcitabine (G) and nab-paclitaxel (nab-P) in patients with refractory advanced pancreatic cancer (PC).
    Ernani, Vinicius
    Akunyili, Ikechukwu Immanuel
    Hosein, Peter Joel
    Macintyre, Jessica
    Lima, Caio Max S. Rocha
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [39] Phase Ib study of gemcitabine, nab-paclitaxel, and ficlatuzumab in patients with advanced pancreatic cancer
    Perez, Kimberly
    Weekes, Colin D.
    Cleary, James M.
    Abrams, Thomas Adam
    Blaszkowsky, Lawrence Scott
    Enzinger, Peter C.
    Giannakis, Marios
    Goyal, Lipika
    Meyerhardt, Jeffrey A.
    Rubinson, Douglas Adam
    Yurgelun, Matthew B.
    Stonely, Danielle
    Raghavan, Srivatsan
    Bakir, Basil
    Das, Koushik
    Pitarresi, Jason
    Aguirre, Andrew
    Needle, Michael N.
    Rustgi, Anil
    Wolpin, Brian M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [40] Gemcitabine (G) plus nab-paclitaxel (nab-P) plus chemoradiation (CRT) in locally advanced pancreatic cancer (LAPC)
    Olowokure, Olugbenga Olanrele
    Bedoya, Ivan Dario
    Mierzwa, Michelle Lynn
    Torregroza, Maria Patricia
    Dwivedi, Alok Kumar
    Wang, Jiang
    Smith, Milton T.
    Schmulewitz, Nathan
    Kucera, Stephen
    Choe, Kyuran Ann
    Ristagno, Ross
    Rudich, Steven
    Sussman, Jeffrey J.
    Ahmad, Syed A.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345